This April 28, 2009 photo shows Novavax, a Rockville, Maryland, company that in 2005 turned its attention to flu vaccines, is testing cell-based technologies to enable it to produce a flu vaccine in as little as three months, half as long as traditional flu vaccine makers, which use an egg-based process. Mandatory Credit: Paul J. Richards/AFP/Getty Images